Calumet Specialty Products (CLMT) Posts Q2 Net Income of $1.14/Share

Calumet Specialty Products (NASDAQ: CLMT) reported Q2 EPS of $1.14, $0.61 better than the analyst estimate of $0.53. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $994.27 million.

For earnings history and earnings-related data on Calumet Specialty Products (CLMT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77